Phapros Tbk PT

Phapros Tbk PT has a liquidity profile that is characterized by a current ratio of 2.29, indicating a moderate ability to meet short-term obligations. The company's liquidity_fpt metric suggests that it maintains a level of liquidity that is in line with industry norms, although its cash and equivalents of 70,399,999,000 IDR are significantly lower than its long-term debt of 706,657,464,000 IDR, which results in a debt-to-equity ratio of 1.7. The company's profitability is reflected in its return on equity (ROE) of 6.76% and return on assets (ROA) of 2.02%, which are below the industry median for ROE and ROA. The price-to-earnings (PE) ratio of 8.87 is also lower than the industry median, suggesting that the company is undervalued relative to its earnings. Phapros Tbk PT's revenue is distributed across four segments: OTC, Ethical, OGB, and Toll-in. The OTC segment is the most significant contributor to revenue, with products available in pharmacies, grocery stores, stalls, and minimarts. The Ethical and OGB segments target hospitals and government institutions, while the Toll-in segment provides manufacturing services to other pharmaceutical companies. The company's growth trajectory is expected to be modest, with the outlook for the current fiscal year (FY) and the next FY indicating a slight increase in revenue. The company's operating cash flow of 123,757,241,000 IDR and free cash flow of 69,758,011,000 IDR support its ability to fund operations and invest in growth opportunities. The risk assessment for Phapros Tbk PT indicates a medium level of liquidity risk and a low level of dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a challenge in the event of a liquidity crunch. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders. Recent events, including filings and transcripts, have not indicated any significant changes in the company's operations or financial strategy. The company continues to focus on its core segments and is not expected to make any major strategic shifts in the near future.